Executive Profile*

Paul L. Berns

AgeTotal Calculated CompensationThis person is connected to 20 board members in 3 different organizations across 8 different industries.

See Board Relationships
49$515,062

Background*

Mr. Paul L. Berns served as the Chief Executive Officer and President of Anacor Pharmaceuticals, Inc. from March 2014 to June 24, 2016 and served as its Chairman from June 2013 to June 24, 2016. Mr. Berns served as the Chief Executive Officer and President of Allos Therapeutics Inc. from March 9, 2006 to August 2012. He was a self-employed consultant to the pharmaceutical industry from July 2005 to March 2006. He served as the President and Chief Executive Officer at ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Vice President of Marketing
Director
2010-Present
Independent Director

Education*

BS
University of Wisconsin - Madison

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$67,500
Total Calculated Compensation$515,062
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman and Chief Executive Officer
Alkermes plc
$881.0K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$1.2M
Erik Bogsch Chairman, Chief Executive Officer, Managing Director and Member of Executive Board
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
--
Jože Colaric President of Management Board and Chief Executive Officer
KrKa, d.d.
€826.0K
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals PLC
$4.1M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.